Hemoteq
Hemoteq, a wholly-owned Freudenberg Medical product brand founded in 1999 and based in Germany, develops proprietary drug and hydrophilic coatings for drug-device combination products, serving medical device OEMs and pharmaceutical companies through CDMO services and powder/solution product sales.
- Company typePrivate
- Founded1999
- HeadquartersWürselen, Germany
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
What Hemoteq does
Hemoteq AG, founded in 1999 and headquartered in Würselen, Germany, is a developer of specialized coating technologies for medical combination products. The company operates as a wholly-owned product brand under Freudenberg Medical, having been acquired in 2015 and fully integrated in 2025. Its portfolio centers on two proprietary technology lines: Hemoteq drug coatings, which deliver controlled release of active pharmaceutical ingredients for drug-eluting stents, drug-coated balloons, and non-vascular implants; and LUBRITEQ, a UV-curable hydrophilic coating that reduces surface friction for minimally invasive devices. The underlying technology is built on in-house excipient and drug formulations protected by 100+ patents, supported by automated coating machines with proprietary software for repeatable precision and surface modification capabilities including plasma treatment and physical microstructuring.
The business operates as a Contract Development and Manufacturing Organization (CDMO), generating revenue through three streams: volume contract coating services at Freudenberg Medical facilities in Germany, the United States, and Ireland; sale of proprietary coating products as powder or solution for in-house customer application; and coating technology development, process development, and technology transfer services. Pricing is quote-based and structured around multi-year enterprise contracts, with royalty-free models available to reduce long-term customer cost. Customers are primarily medical device OEMs in cardiovascular, interventional, and minimally invasive surgical segments, with a secondary pharmaceutical customer segment for drug-device combination products. GTM is enterprise field sales, supported by digital channels (Freudenberg Medical website, LinkedIn, YouTube, WeChat) and a Knowledge Hub of whitepapers, brochures, and webinars.
The company's competitive position rests on regulatory-grade, clinically validated coatings aligned with FDA, ISO, and MDR requirements, plus vertical integration into Freudenberg Medical's 12-site global manufacturing footprint and 250+-engineer development organization. Key named customer evidence includes a flagship relationship with a leading cardiovascular medical device company for drug-coated balloon catheters, addressing cardiovascular disease which accounts for 30% of global deaths.
Hemoteq firmographics
Firmographics- Name
- Hemoteq
- Legal name
- Hemoteq
- Website
- https://hemoteq.de
- Company type
- Private
- Founded year
- 1999
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Hemoteq, a wholly-owned Freudenberg Medical product brand founded in 1999 and based in Germany, develops proprietary drug and hydrophilic coatings for drug-device combination products, serving medical device OEMs and pharmaceutical companies through CDMO services and powder/solution product sales.
- Ownership category
- akta.pro rank
Hemoteq industry classification
Industry- Product category
- Medical Device Coatings
- NAICS
- Paint and Coating Manufacturing (32551), Medical Equipment and Supplies Manufacturing (3391)
- SIC
- Coating, Engraving & Allied Services (3470)
- akta.pro primary industry
- Specialty & Functional Coatings (Anti-microbial/Anti-slip/Insulating) (IMAIAKAM)
Keywords
Where Hemoteq is headquartered
LocationHeadquarters
- HQ city
- Würselen
- HQ country
- Germany
- HQ region
- Europe
Offices3 records
Markets served
Hemoteq business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Technology or R&D, Operations, Supply Chain, Infrastructure
Revenue model
- Coating Products (Powder/Solution): Customers can purchase proprietary coatings as powder or solution to apply in-house at their own facilities
- Contract Coating Services: Volume coating production services at Freudenberg facilities in U.S., Ireland, or Germany for medical devices and components
- Coating Technology Development: Coating design, process development, iterative prototyping, pilot production, and technology transfer services for drug-device combination products
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Multi-year contract | Custom CDMO coating services - quote-based pricing |
Go-to-market motion1 record
Distribution channels2 records
Marketing channels6 records
Hemoteq product offering
Product offeringCore offering
Hemoteq develops and manufactures proprietary medical coating solutions for drug-device combination products (DDCP), including drug coatings for drug eluting stents, drug coated balloons, and non-vascular implants. It also provides advanced UV-curable hydrophilic coatings (under the LUBRITEQ brand) and surface modification services for minimally-invasive medical devices. Offerings include both coating products sold as powder/solution for in-house application and contract coating services performed at Freudenberg Medical facilities.
Product overview
Hemoteq is an established product brand under Freudenberg Medical focused on drug coatings for medical devices. The portfolio includes two main product lines: Hemoteq for drug coatings and LUBRITEQ™ for advanced hydrophilic coatings solutions. These offerings are part of Freudenberg Medical's broader CDMO (Contract Development and Manufacturing Organization) services for drug-device combination products, providing coating design, process development, regulatory strategy, and volume production of specialty coated components.
Differentiator
Problem solved
Functional benefit
Products and services
- Hemoteq Drug Coatings Proprietary drug coating formulations for drug-device combination products, enabling controlled and precise delivery of active pharmaceutical ingredients with specified release profiles for optimal clinical performance. Designed for medical device OEMs developing interventional cardiovascular devices and implants.
- LUBRITEQ Hydrophilic Coatings UV-curable hydrophilic coating solution for medical devices that reduces surface friction and delivers exceptional lubricity for minimally-invasive medical devices. Validated in clinical applications and aligned with FDA, ISO, and MDR regulatory requirements.
- Surface Modifications Tailored surface property modification services including wettability control, friction reduction, anti-tack properties, and controlled drug release. Uses physical microstructuring, plasma treatment, and proprietary drop-drag-coating processes for medical device manufacturers.
- Automated Coating Machines Automated coating machinery with proprietary software and calibratable coating settings designed to ensure coating consistency, precision, and reliability for medical device manufacturing.
- Contract Coating Services Contract Development and Manufacturing Organization (CDMO) services for medical device coatings, including coating design, process development, iterative prototyping, pilot production, technology transfer, and volume coating production for medical devices and components.
Quantifiable outcome
- Reduced surface friction and exceptional lubricity for minimally-invasive devices
- +3 more outcomes
Companies that use Hemoteq
Customer profileNamed customers1 record
Segments2 records
Ideal customer profiles2 records
Hemoteq technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
Hemoteq partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- Hemoteq AGcoreFreudenberg Medical acquired Hemoteq in 2015 to strategically expand expertise in medical coatings. The acquisition brought proprietary drug coating formulations, 25+ years of coating expertise, and established market presence in drug-device combination products. Full integration was completed in 2025, enabling Freudenberg to offer development, manufacturing, and coating from a single source.
Scale indicators5 records
Recent moves6 records
Expansion highlights5 records
Hemoteq competitors and assessment
Company assessmentMarket position
Competitive moat5 records
Key risks6 records
Key highlights6 records
Customer concentration
Hemoteq social profiles
Digital presenceHemoteq financial estimates
Financial estimateRevenue estimate
Valuation estimate
Hemoteq leadership team
Management profileNumber of profiles
Profiles1 record
Hemoteq funding detail
Funding detailFunding overview
Funding rounds3 records
Investors3 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Hemoteq M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Hemoteq
What does Hemoteq do?
Hemoteq develops and manufactures proprietary medical coating solutions for drug-device combination products (DDCP), including drug coatings for drug eluting stents, drug coated balloons, and non-vascular implants. It also provides advanced UV-curable hydrophilic coatings (under the LUBRITEQ brand) and surface modification services for minimally-invasive medical devices. Offerings include both coating products sold as powder/solution for in-house application and contract coating services performed at Freudenberg Medical facilities.
Is Hemoteq a public or private company?
Hemoteq is a private company. It is classified as corporate owned and is currently operating.
When was Hemoteq founded?
Hemoteq was founded in 1999. It employs 11 to 50 people.
Where is Hemoteq based?
Hemoteq is headquartered in Würselen, Germany, in the Europe region.
How does Hemoteq make money?
Three revenue lines are on record. Coating Products (Powder/Solution) is the primary driver. The others are contract Coating Services and coating Technology Development.
Does Hemoteq have an API?
No public API is recorded for Hemoteq.
What industry is Hemoteq in?
Hemoteq's product category is Medical Device Coatings. Its primary akta.pro industry code is IMAIAKAM, Specialty & Functional Coatings (Anti-microbial/Anti-slip/Insulating). Its NAICS code is 32551 and its SIC code is 3470.